C4PAIN ApS: Financial statements 2013
CVR: 32292402
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
C4PAIN ApS (CVR 32292402) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -448,496 and a net result of DKK 1,596,308 compared with DKK -385,626 the year before. Equity in the 2013 report amounted to DKK 519,805. The solvency ratio was 18.3%.
- Gross Profit
- DKK -448,496
- Profit/Loss
- DKK 1,596,308
- Equity
- DKK 519,805
- Total Assets
- DKK 2,838,212
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -448 t. | 1.6 mio. | 520 t. | - |
| 2012 | - | 2.1 mio. | -386 t. | 2.7 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
C4PAIN ApS has published its annual report for 2012. Gross profit came to DKK 2,115,047, and the net result was DKK -385,626.
About C4PAIN ApS
C4PAIN ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Arendt-Nielsen. The company is owned by BIO-MEDICAL CONSULT HOLDING ApS. The company has 0 employees (2014). In 2025, the company reported a gross profit of DKK 159,243 and a net result of DKK 185,909 compared with DKK 1,074,600 the year before. Equity in the 2025 report amounted to DKK 4,164,765.